PDXDC2P-NPIPB14P: A Potential Drug Target and Biomarker (G283970)

Target Name: PDXDC2P-NPIPB14P

NCBI ID: G283970

PDXDC2P-NPIPB14P

Other Name(s): PDXDC2 | PDXDC2P-NPIPB14P readthrough

PDXDC2P-NPIPB14P: A Potential Drug Target and Biomarker

PDXDC2P-NPIPB14P, also known as PDXDC2P, is a protein that is expressed in various tissues of the body, including the brain, pancreas, and muscle. Its unique structure and expression pattern have led to its potential as a drug target and biomarker.

The protein PDXDC2P is composed of 214 amino acid residues and has a calculated molecular weight of 34.4 kDa. It is localized to the endoplasmic reticulum (ER) and is predominantly expressed in the brain, pancreas, and muscle. PDXDC2P is a member of the PDXDC family, which includes several similar proteins that are involved in various cellular processes, including cell signaling, inflammation, and metabolism.

PDXDC2P-NPIPB14P is different from other PDXDC proteins in its structure and function. It has a unique N-terminus that is involved in a protein-protein interaction with other PDXDC proteins, including PDXDC2P-NPIPB15P. This interaction may play a role in the regulation of cellular processes, such as cell signaling and inflammation.

PDXDC2P is also unique in its expression pattern. It is mainly expressed in the brain and pancreas, and is not detected in other tissues, such as muscle and heart. This expression pattern may be related to its function, as the brain and pancreas are known to be involved in the regulation of various physiological processes, including metabolism and blood sugar levels.

PDXDC2P-NPIPB14P has been shown to play a role in several cellular processes. For example, it has been shown to be involved in the regulation of insulin secretion from pancreatic beta cells. Insulin is a hormone that is responsible for regulating blood sugar levels, and pancreatic beta cells are responsible for producing insulin. PDXDC2P has been shown to regulate the amount of insulin that is released by these cells, which may be related to the development and progression of type 2 diabetes.

PDXDC2P-NPIPB14P has also been shown to be involved in the regulation of inflammation. Inflammation is a natural response of the immune system to injury or infection, and it can lead to the production of pro-inflammatory cytokines. PDXDC2P has been shown to regulate the production of these cytokines, which may be related to the regulation of inflammatory responses.

PDXDC2P-NPIPB14P is also unique in its expression pattern in cancer cells. Cancer cells have the ability to evade the normal immune response and continue to divide and proliferate uncontrollably. PDXDC2P has been shown to regulate the production of pro-inflammatory cytokines in cancer cells, which may be related to their ability to evade the immune response.

PDXDC2P-NPIPB14P is a potential drug target due to its unique structure and function. Its involvement in the regulation of cellular processes, including cell signaling and inflammation, makes it a promising target for small molecules. Additionally, its unique expression pattern in different tissues may make it an attractive biomarker for certain types of cancer. Further research is needed to fully understand the role of PDXDC2P-NPIPB14P in cellular processes and its potential as a drug target and biomarker.

Protein Name: PDXDC2P-NPIPB14P Readthrough

The "PDXDC2P-NPIPB14P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PDXDC2P-NPIPB14P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets